Article · Journal · 2019

The efficacy and safety of rosiglitazone with concurrent sulphonylurea therapy in subjects with type 2 diabetes mellitus in Nigeria

International Journal of Diabetes and Metabolism

Citations: 1from other works
Field-weighted impact: 0.001.00 is the world average for its field and year
Among its field: 1st percentileby citations, against works of its field and year
Authors: 4from 3 institutions

Authors

4 authors across 3 institutions in 1 country